Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
1 hedge funds and large institutions have $2K invested in Biofrontera AG American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
99% less capital invested
Capital invested by funds: $321K → $2K (-$319K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$314K |
| 2 |
ANBT
American National Bank & Trust
Wichita Falls,
Texas
|
-$7K |
BFRA Hedge Fund Activity: Q2 2020 in Review
1 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q2 2020, worth a combined $2K — down 99% from $321K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BFRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.59K. The largest seller was Sowell Financial Services, exiting entirely with an estimated $314K sold.
- 1 institutional investor held Biofrontera AG American Depositary Shares (BFRA) as of Q2 2020, down from 3 in Q1 2020.
- Funds reported $2K of Biofrontera AG American Depositary Shares stock for Q2 2020, down 99% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q2 2020 and 2 closed out, a net change of -2 holders.
- The largest Biofrontera AG American Depositary Shares buyer in Q2 2020 was UBS Group, an estimated $1.59K added.
- The largest Biofrontera AG American Depositary Shares seller in Q2 2020 was Sowell Financial Services, an estimated $314K sold.
Based on aggregated 13F filings for Q2 2020.